Omeros Corporation (OMER)

NASDAQ
3.24
+0.02(+0.63%)
  • Volume:
    71,649
  • Day's Range:
    3.18 - 3.30
  • 52 wk Range:
    1.86 - 9.78

OMER Overview

Prev. Close
3.22
Day's Range
3.18-3.3
Revenue
58.82M
Open
3.2
52 wk Range
1.86-9.78
EPS
3.1
Volume
71,649
Market Cap
203.25M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,015,357
P/E Ratio
-
Beta
1.13
1-Year Change
-75.97%
Shares Outstanding
62,730,015
Next Earnings Date
09 Nov 2022
What is your sentiment on Omeros?
or
Vote to see community's results!

Omeros Corporation News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Omeros Corporation Analysis

Omeros Corporation Company Profile

Omeros Corporation Company Profile

Employees
213

Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic diseases, including complement-mediated diseases and cancers related to dysfunction of the immune system, as well as addictive and compulsive disorders. Its lead lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA). Narsoplimab is also in multiple late-stage clinical development programs focused on other complement-mediated disorders, including IgA nephropathy, atypical hemolytic uremic syndrome, and COVID-19. OMS906, its inhibitor of MASP-3, an activator of the alternative pathway of complement, is initiating a Phase I b clinical program in paroxysmal nocturnal hemoglobinuria (PNH).

Read More

Analyst Price Target

Average12.00 (+270.37% Upside)
High20
Low4
Price3.24
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellStrong SellStrong Sell
Technical IndicatorsStrong SellBuyStrong SellStrong SellStrong Sell
SummaryStrong SellNeutralStrong SellStrong SellStrong Sell